The FDA has accepted Stealth…
The FDA has accepted Stealth BioTherapeutics’ third new drug application [...]
Gilead has become the latest…
Gilead has become the latest pharma to strengthen its in [...]
Dynavax’s lofty ambition to…
Dynavax’s lofty ambition to snatch Shingrix’s crown got off to [...]
The FDA has extended its target…
The FDA has extended its target action dates for two [...]
Unregulated Sexual Stimulants Flood West Africa
Unregulated sexual stimulants claiming to be herbal remedies or pharmaceuticals [...]
A year after earning FDA approval…
A year after earning FDA approval for Kisunla, Eli Lilly [...]
The FDA has freed Rocket…
The FDA has freed Rocket Pharmaceuticals from a clinical hold, [...]
Xoma Royalty is ravenous for…
Xoma Royalty is ravenous for biotechs, and the Bay Area [...]
The first half of 2025 was brutal…
The first half of 2025 was brutal for biotech, but [...]
Several U.S. pharma companies that…
Several U.S. pharma companies that had posted revenue declines in [...]